PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Barcelona, and Autoimmune Diseases Unit, Department of Internal Medicine, Hospital CIMA- Sanitas, Barcelona, Spain.\', \'Centre d\'Atenció Primària Les Corts, Consorci d\'Atenció Primària de Salut Barcelona Esquerre (CAPSBE), Barcelona; Grup Tranversal de Recerca en Atenció Primària, Institut d\'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona; and Department of Medicine, Universitat de Barcelona, Barcelona, Spain. asiso@clinic.cat.\', \'Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Barcelona, Spain.\', \'Rheumatology Department, Hospital Universitari Parc Taulí, Sabadell, Barcelona; Instituto Modelo de Cardiología Privado SRL, Córdoba, and Instituto Universitario de Ciencias Biomédicas de Córdoba (IUCBC), Argentina.\', \'Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Barcelona; Department of Medicine, Universitat de Barcelona, and Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, Spain.\']
?:citedBy
  • -1
?:creator
?:hasPublicationType
?:journal
  • Clinical and experimental rheumatology
is ?:pmid of
?:pmid
?:pmid
  • 34001305
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 85
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 infection in patients with systemic autoimmune diseases.
?:type

Metadata

Anon_0  
expand all